Scinovex
reviewTop 1% cited

GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration

American Journal of Kidney Diseases · 2014 · Vol. 64(6) · pp. 821–835
Andrew S. LeveyLesley A. InkerKunihiro MatsushitaTom GreeneKerry WillisEdmund J. LewisDick de ZeeuwAlfred K. CheungJosef Coresh
Chronic Kidney Disease and DiabetesDialysis and Renal Disease ManagementAcute Kidney Injury ResearchMedicineKidney diseaseRenal functionCreatinineClinical trialIntensive care medicineSurrogate endpointFood and drug administrationClinical endpointInternal medicine

MeSH terms

Clinical Trials as TopicEducationFoundationsGlomerular Filtration RateHumansUnited StatesUnited States Food and Drug AdministrationEndpoint DeterminationRenal Insufficiency, Chronic

Funding

  • Amgen
  • Gilead Sciences
  • Tufts Medical Center
Citations
577
FWCI
20.24
field-weighted impact
References
44
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.